These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 24631188

  • 1. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
    Miura T, Hidaka K, Azai Y, Kashimoto K, Kawasaki Y, Chen SE, de Freitas RF, Freire E, Kiso Y.
    Bioorg Med Chem Lett; 2014 Apr 01; 24(7):1698-701. PubMed ID: 24631188
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics.
    Nguyen W, Hodder AN, de Lezongard RB, Czabotar PE, Jarman KE, O'Neill MT, Thompson JK, Jousset Sabroux H, Cowman AF, Boddey JA, Sleebs BE.
    Eur J Med Chem; 2018 Jun 25; 154():182-198. PubMed ID: 29800827
    [Abstract] [Full Text] [Related]

  • 4. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
    Hidaka K, Kimura T, Tsuchiya Y, Kamiya M, Ruben AJ, Freire E, Hayashi Y, Kiso Y.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3048-52. PubMed ID: 17400453
    [Abstract] [Full Text] [Related]

  • 5. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
    Hidaka K, Kimura T, Ruben AJ, Uemura T, Kamiya M, Kiso A, Okamoto T, Tsuchiya Y, Hayashi Y, Freire E, Kiso Y.
    Bioorg Med Chem; 2008 Dec 01; 16(23):10049-60. PubMed ID: 18952439
    [Abstract] [Full Text] [Related]

  • 6. Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.
    Miura T, Hidaka K, Uemura T, Kashimoto K, Hori Y, Kawasaki Y, Ruben AJ, Freire E, Kimura T, Kiso Y.
    Bioorg Med Chem Lett; 2010 Aug 15; 20(16):4836-9. PubMed ID: 20634066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
    Abdel-Rahman HM, Kimura T, Hidaka K, Kiso A, Nezami A, Freire E, Hayashi Y, Kiso Y.
    Biol Chem; 2004 Nov 15; 385(11):1035-9. PubMed ID: 15576323
    [Abstract] [Full Text] [Related]

  • 9. Antiplasmodial activities of 4-aminoquinoline-statine compounds.
    Vaiana N, Marzahn M, Parapini S, Liu P, Dell'Agli M, Pancotti A, Sangiovanni E, Basilico N, Bosisio E, Dunn BM, Taramelli D, Romeo S.
    Bioorg Med Chem Lett; 2012 Sep 15; 22(18):5915-8. PubMed ID: 22884991
    [Abstract] [Full Text] [Related]

  • 10. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
    Nezami A, Luque I, Kimura T, Kiso Y, Freire E.
    Biochemistry; 2002 Feb 19; 41(7):2273-80. PubMed ID: 11841219
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitors of Plasmepsin II-potential antimalarial agents.
    Corminboeuf O, Dunet G, Hafsi M, Grimont J, Grisostomi C, Meyer S, Binkert C, Bur D, Jones A, Prade L, Brun R, Boss C.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6194-9. PubMed ID: 17000102
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V, Zimmermann M, Maass A, Schwichtenberg H, Wolf A, Jacq N, Breton V, Hofmann-Apitius M.
    J Chem Inf Model; 2007 Dec 15; 47(5):1818-28. PubMed ID: 17727268
    [Abstract] [Full Text] [Related]

  • 19. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L, Rizzi L, Pedretti A, Taglialatela-Scafati O, Carucci M, Pancotti A, Galli C, Read M, Giurisato E, Romeo S, Russo I.
    PLoS One; 2015 Dec 15; 10(11):e0142509. PubMed ID: 26566224
    [Abstract] [Full Text] [Related]

  • 20. Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.
    Bobrovs R, Jaudzems K, Jirgensons A.
    J Med Chem; 2019 Oct 24; 62(20):8931-8950. PubMed ID: 31062983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.